Scadenza: 25 January 2022
Topic:
The action aims to reduce the risk of liver cancers associated with infections caused by the Hepatitis B and Hepatitis C viruses and the risk of gastric cancers caused by Helicobacter pylori.
Each of the three types of infectious agents will be addressed by specific approaches targeted to support vaccination in case of Hepatitis B virus and to drug treatment in case of Hepatitis C virus and Helicobacter pylori. Specific activities will be dedicated to the early detection of infections, the cornerstone strategy to reduce the risk of liver and gastric cancer caused by the three mentioned pathogens.
Programma:
EU4 Health Programme (EU4H)
Ente finanziatore:
EU
Budget complessivo:
EUR 2 000 000
Duration of the project: Proposals should range between 12 and 36 months, the recommended length of a project is 24 months.
Who can participate:
Applications by either a sole applicants or by a consortium are acceptable
Partnership: Not Mandatory
Status:
Closed
Quota finanziabile:
100%
Topic:
The action aims to reduce the risk of liver cancers associated with infections caused by the Hepatitis B and Hepatitis C viruses and the risk of gastric cancers caused by Helicobacter pylori.
Each of the three types of infectious agents will be addressed by specific approaches targeted to support vaccination in case of Hepatitis B virus and to drug treatment in case of Hepatitis C virus and Helicobacter pylori. Specific activities will be dedicated to the early detection of infections, the cornerstone strategy to reduce the risk of liver and gastric cancer caused by the three mentioned pathogens.
Who can participate:
Applications by either a sole applicants or by a consortium are acceptable
Programme:
EU4 Health Programme (EU4H)
Consortium: Not required
Status: Open
Total budget:
EUR 2 000 000
Funding rate:
100%
Notes:
Proposals to be awarded under this topic: Up to two proposals – One targeted to HBV and HCV and one targeted to Helicobacter pylori
